Greenland Mines Ltd (GRML)
| Market Cap | 52.13M +1,050.0% |
| Revenue (ttm) | n/a |
| Net Income | -10.55M |
| EPS | -0.22 |
| Shares Out | 121.24M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,637,466 |
| Open | 0.4650 |
| Previous Close | 0.4601 |
| Day's Range | 0.4300 - 0.4756 |
| 52-Week Range | 0.1154 - 3.9100 |
| Beta | 2.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 13, 2026 |
About GRML
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer’s disease, as well as therapies to treat Parkinson’s and other age-related disorders. ... [Read more]
Financial Performance
Financial StatementsNews
Greenland Mines Reports Up To 45% – 55% Increase in Palladium Equivalent (PdEq) Grades at Skaergaard in Sensitivity Study
CHARLOTTE, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Greenland Mines Ltd (“Greenland Mines” or the “Company”) (Nasdaq: GRML) reports the results of an independent metal price sensitivity analysis complet...
Greenland Mines (Nasdaq: GRML) Reports 45–55% PdEq Grade Uplift in Metal-Price Sensitivity at Skaergaard — While Western Critical Minerals Push Hits Inflection Point
Companies Mentioned: NASDAQ: GRML | NASDAQ: USAR KEY TAKEAWAYS Greenland Mines Ltd. (Nasdaq: GRML) has reported the results of an independent metal-price sensitivity analysis on its Skaergaard Project...
Greenland Mines Reports Up To 45% - 55% Increase in Palladium Equivalent (PdEq) Grades at Skaergaard in Sensitivity Study
CHARLOTTE, N.C., May 7, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) reports the results of an independent metal price sensitivity analysis completed by...
Brussels Just Opened Its Critical-Raw-Materials Door to a Greenland Palladium-Gold-Platinum Project — and the Company Behind It Trades on the Nasdaq
Greenland Mines Ltd. (NASDAQ: GRML) and its 80%-owned Greenland subsidiary Major Precious Greenland A/S have been admitted to the European Raw Materials Alliance — the European Commission's central in...
Greenland Mines And Its Subsidiary Major Precious Greenland A/S Join the European Raw Materials Alliance
CHARLOTTE, N.C., May 5, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) is pleased to announce that the Company and its 80%-owned Greenland subsidiary Majo...
Greenland Mines (NASDAQ: GRML) Locks In World-Class Technical Team for $68B Skaergaard PGM-Gold Deposit as Western Critical Minerals Push Accelerates
Issued on behalf of Greenland Mines Ltd SECTOR INTELLIGENCE BRIEF | In five weeks, Greenland Mines has assembled SLR Consulting (geological / Qualified Person), GTK Mintec (metallurgy and pilot proces...
Greenland Mines Appoints SLR Consulting as Geological Consultant and Qualified Person for Skaergaard
CHARLOTTE, N.C., April 27, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") announces the appointment of SLR Consulting ("SLR") as geological consultant and...
Greenland Mines Engages GTK Mintec for Comprehensive Metallurgical and Processing Flow Program at Skaergaard
Establishes end-to-end processing and pilot testing program to unlock multi-metal value at Skaergaard CHARLOTTE, N.C., April 23, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Com...
GREENLAND MINES ENTERS INTO LOI TO EVALUATE BROWNFIELD DOWNSTREAM ICELANDIC INDUSTRIAL PROCESSING SITE, OUTLINES STRATEGIC SUPPLY CHAIN SECURITY PROGRAM
CHARLOTTE, N.C., April 16, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) has entered into a non-binding Letter of Intent with an Icelandic industrial sit...
Greenland Mines Subsidiary Major Precious Greenland A/S Joins Greenland Business Association
Enhances stakeholder engagement and supports long-term project development in Greenland CHARLOTTE, N.C., April 2, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Com...
Greenland Mines Secures Icebreaker Argus For 2026 Skaergaard Field Program
Ice-class vessel deployment strengthens Arctic logistics infrastructure and enables efficient execution of the 2026 Skaergaard field program CHARLOTTE, N.C., March 25, 2026 /PRNewswire/ -- Greenland M...
Greenland Mines Secures Additional 180-Day Period for Nasdaq Bid Price Compliance
Extension reflects Company's continued compliance with all other applicable Nasdaq listing requirements CHARLOTTE, N.C., March 23, 2026 /PRNewswire/ -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland M...
Greenland Mines Engages WSP Denmark to Launch Comprehensive Environmental Baseline Program at Skaergaard Mining Site
Engagement supports exploitation license pathway while advancing responsible, large-scale development of the Skaergaard Project CHARLOTTE, N.C., March 19, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Gr...
Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML
Company to hold investor webcast on March 12, 2026 at 4:15PM ET to discuss its expanded focus on critical minerals development in Greenland CHARLOTTE, N.C., March 12, 2026 /PRNewswire/ -- Klotho Neuro...
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR
Transaction delivers shareholders direct ownership in one of the largest undeveloped palladium-gold deposits on Earth, establishing a new western champion in critical mineral supply security; Company ...
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
The Company enlists industry veteran Dr. Bret Barnes to oversee the development of new diagnostic offerings NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the Company)...
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence
NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO) ("Klotho" or the Company) announces the acceptance of 18 claims within a patent application filed in Australia for com...
Klotho Neurosciences to Present at the Biotech Showcase 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company"), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting...
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award
NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth ...
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team will atte...
Klotho Neurosciences Announces Expiration of Letter of Intent
NEW YORK , Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire ...
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership
NEW YORK and PALO ALTO, Calif. , Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of Intent (LOI) to acquire s...
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative diseas...
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market
Key partnerships, regulatory progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeutics NEW YORK , Aug. 18, 2025 /PRNewswire...
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and development of its KLTO-202 gene therapy ...